BioWorld: The Daily Biopharmaceutical News Source
Daily news and analysis of the global biotechnology and pharmaceutical industries. In-depth coverage of business, financing, regulation, science, innovation, drug approvals, clinical trials and more.
BioWorld: The Daily Biopharmaceutical and Medical Technology …
These cookies are used to enable social media sharing or “like” buttons on our services. They also provide the ability to link your account or engage with our content on or through a social media platform such as Facebook, Twitter or LinkedIn.
China - Articles - BioWorld
5 days ago · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more
| BioWorld
May 14, 1992 · Scios Inc. and Nova Pharmaceutical Corp. announced onWednesday that they will merge in an exchange of stockvalued at $180 million. The company, to be called Scios-Nova Inc., will combine Scios'expertise in biotechnology with Nova's strength in smallmolecules, receptor technology and rational drug design, saidRichard Casey, president and chief executive of Scios.
Antibody - Articles | BioWorld
Dec 20, 2024 · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more
Conferences - Articles | BioWorld
Dec 24, 2024 · Gait instability and somnolence are the main hindbrain-related adverse effects associated with the inhibition of AMPA receptors (AMPARs). Transmembrane AMPAR regulatory proteins (TARPs) modulate AMPAR function, with the specific member TARPγ8 being highly expressed in brain regions associated with seizures and expressed at low or negligible levels in …
Marian (YoonJee) Chu - BioWorld
BioWorld - Marian (YoonJee) Chu. AI pulled in major financings and approvals for Asia med-techs in 2024 as Asia Pacific countries played to individual strengths to maximize AI’s applications in the health care sector.
| BioWorld
Nov 22, 2024 · As a new BioWorld new investigative report shows, decades of research excluding women from clinical trials and investment decisions made in male-dominated boardrooms have led to half the world’s health needs being underserved.Of the drug development companies working on women's health solutions, the proportion of …
Coronavirus - Articles - BioWorld
Dec 10, 2024 · The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration.Note that we have added three critical tables, which are continuously updated:
Europe - Articles - BioWorld
Dec 23, 2024 · Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more